What's SR 9009?

Posted by Thomas Shaw on August 12th, 2018

SR 9009, also called Stenabolic, was developed by The Scripps Study Institute by professor Thomas Burris, Ph.D, Professor and Director in the Center for Diabetes and Metabolic Diseases. Professor Burris does study in drug discovery development for sort 1 and form 2 diabetes, obesity and atherosclerosis (clogged arteries), and around the partnership in between circadian rhythms and metabolic ailments. He is one of several prime developers of drugs that affect metabolism and power levels. He is also an specialist on metabolic ailments and conditions, plus the effect of circadian rhythms upon them. Get much more details about sr9009

SR 9009 is a nuclear receptor reversed-viral erythroblastosis a (Rev-erba) ligand which can be taken orally. It's out there in powder, liquid, and capsule forms. Rev-erba regulates the expression of core clock proteins and therefore aids to modulate circadian rhythm. This could affect metabolism, power levels, stamina, and mobility.